https://www.selleckchem.com/products/cp-43.html
Four prospective studies and one retrospective study were included with a total of 810 patients. We found auto-HSCT was superior to allo-HSCT in OS (HR = 1.42, 95% CI 1.06-1.91, P = 0.02), and there was no difference between allo-HSCT and auto-HSCT for RFS (HR = 1.10, 95% CI 0.86-1.40, P = 0.44) and RR (OR = 0.53, 95% CI 0.22-1.26, P = 0.15). The risk of TRM for patients undergoing allo-HSCT was significantly higher than that of the patients who received auto-HSCT (OR = 5.06, 95% CI 1.03-24.75, P = 0.05). Our meta-analysis shows that auto
Like
Comment
Share
